In the field of pharmaceuticals, Manac carries out joint development of bulk pharmaceuticals and intermediates (stage prior to bulk pharmaceuticals) as well as supplying of raw materials in response to the requests of numerous pharmaceutical firms. Since organic intermediates that make use of halogenation techniques can be effective as pharmaceutical intermediates, Manac's pharmaceutical business is raising many expectations. With commissioned production of pharmaceutical intermediates(Commissioned production from intermediates to final bulk pharmaceuticals is possible.)as an axis, we shall develop our business by stepping one step further into production of progenitor materials.
[Supported fields]
We deliver assured quality through ensured technologies.
We deliver quality that our customers can be sure of through full use of our synthesis technologies, process technologies, and analysis technologies, which we have cultivated over the years, and GMP management coupled with ISO9001 and ISO14001. We are also upgrading the GMP towards achieving global standard quality.
We are planning the construction of a new facility integrating the processes from final refining to drying and packaging by 2005 and shall continue to make more attractive propositions as Manac.
